scholarly journals Acute Kidney Injury Secondary to Rhabdomyolysis and COVID-19: A Case Report and Literature Review

2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Vishaka K. Chetram ◽  
Akram I. Ahmad ◽  
Saira Farid ◽  
Tanuj Sood

The viral infection causing COVID-19 most notably affects the respiratory system but can result in extrapulmonary clinical manifestations as well. Rhabdomyolysis-associated acute kidney injury (AKI) in the setting of COVID-19 is an uncommon complication of the infection. There is significant interest in this viral infection given its global spread, ease of transmission, and varied clinical manifestations and outcomes. This case report and literature review describes the symptoms, laboratory findings, and clinical course of a patient who developed AKI secondary to rhabdomyolysis and COVID-19, which will help clinicians recognize and treat this condition.

2016 ◽  
Author(s):  
B Li ◽  
Q Wen ◽  
Z Gao ◽  
Z Hu ◽  
X Yang ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-3 ◽  
Author(s):  
Fareed B. Kamar ◽  
Rory F. McQuillan

Cholestyramine is a bile acid sequestrant that has been used in the treatment of hypercholesterolemia, pruritus due to elevated bile acid levels, and diarrhea due to bile acid malabsorption. This medication can rarely cause hyperchloremic nonanion gap metabolic acidosis, a complication featured in this report of an adult male with concomitant acute kidney injury. This case emphasizes the caution that must be taken in prescribing cholestyramine to patients who may also be volume depleted, in renal failure, or taking spironolactone.


2013 ◽  
Vol 52 (21) ◽  
pp. 2457-2460 ◽  
Author(s):  
Sahoko Chiba ◽  
Kimitake Tsuchiya ◽  
Hiroyuki Sakashita ◽  
Eisaku Ito ◽  
Naohiko Inase

Sign in / Sign up

Export Citation Format

Share Document